Fujimiya Tsuyoshi, Seto Yuki, Ishida Keiichi, Takase Shinya, Satokawa Hirono, Yokoyama Hitoshi
Department of Cardiovascular Surgery, Fukushima Medical University, Fukushima, Japan.
J Vasc Surg Cases Innov Tech. 2021 Feb 26;7(2):219-222. doi: 10.1016/j.jvscit.2021.02.002. eCollection 2021 Jun.
Endovascular aortic aneurysm repair (EVAR) is a valid treatment for patients with abdominal aortic aneurysm with aortocaval fistula. However, an endoleak can be caused by persistent communication between the aneurysm and the inferior vena cava. We present a case of impending rupture due to spontaneous obstruction of an aortocaval fistula after EVAR. Spontaneous obstruction of an aortocaval fistula is rare; however, when occurs, it will cause an endoleak, followed by dilatation or impending rupture of the abdominal aortic aneurysm. EVAR alone for aortocaval fistula will sometimes not be adequate if the type II endoleak is patent.
血管腔内主动脉瘤修复术(EVAR)是治疗腹主动脉瘤合并主动脉腔静脉瘘患者的有效方法。然而,动脉瘤与下腔静脉之间的持续连通可导致内漏。我们报告1例EVAR术后因主动脉腔静脉瘘自发阻塞而濒临破裂的病例。主动脉腔静脉瘘的自发阻塞很少见;然而,一旦发生,就会导致内漏,继而引起腹主动脉瘤扩张或濒临破裂。如果Ⅱ型内漏持续存在,单纯的EVAR治疗主动脉腔静脉瘘有时并不充分。